Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 124, Issue 1, 2006, Pages 3-9

  Thiébaut, Rodolphe ^a   Leroy, Valériane ^a   Alioum, Ahmadou ^a   Binquet, Christine ^c   Poizat, Gwendoline ^a   Salmi, L Rachid ^a,b   Gras, Luuk ^d   Salamon, Roger ^a   Gilbert, Ruth ^d   Chêne, Geneviève ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biases; Congenital toxoplasmosis; Epidemiologic studies; Meta analyses; Systematic review

Indexed keywords

COHORT ANALYSIS; GESTATIONAL AGE; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SEROCONVERSION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 29644443709     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.07.019     Document Type: Review

References (31)

1. G. Desmonts, and J. Couvreur Congenital toxoplasmosis. A prospective study of 378 pregnancies N Engl J Med 290 1974 1110 1116
2. J. McAuley, K.M. Boyer, and D. Patel Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial Clin Infect Dis 18 1994 38 72
3. D. Jeannel, D. Costagliola, G. Niel, B. Hubert, and M. Danis What is known about the prevention of congenital toxoplasmosis? Lancet 336 1990 359 361
4. W. Foulon, I. Villena, and B. Stray-Pedersen Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year Am J Obstet Gynecol 180 1999 410 415
5. European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003;110:112-20.
6. A. Vimercati, M.C. Angelici, and L. De Cosmo Prevention and treatment of congenital toxoplasmosis: organization protocol Minerva Ginecol 56 2004 171 178
7. A. Eskild, A. Oxman, P. Magnus, A. Bjorndal, and L.S. Bakketeig Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? J Med Screen 3 1996 188 194
8. M. Wallon, C. Liou, P. Garner, and F. Peyron Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy BMJ 318 1999 1511 1514
9. F. Daffos, F. Forestier, and M. Capella-Pavlovsky Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis N Engl J Med 318 1988 271 275
10. R. Gilbert, D. Dunn, and M. Wallon Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol Epidemiol Infect 127 2001 113 120
11. R.E. Gilbert, L. Gras, M. Wallon, F. Peyron, A.E. Ades, and D.T. Dunn Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France Int J Epidemiol 30 2001 1303 1308
12. L. Gras, R.E. Gilbert, A.E. Ades, and D.T. Dunn Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis Int J Epidemiol 30 2001 1309 1313
13. A. Eskild, and P. Magnus Commentary: little evidence of effective prenatal treatment against congenital toxoplasmosis - the implications for testing in pregnancy Int J Epidemiol 30 2001 1314 1315
14. P. Thulliez Commentary: efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out Int J Epidemiol 30 2001 1315 1316
15. K.J. Rothman, and S. Greenland Modern epidemiology 2nd ed. 1998 Lippincott Raven Philadelphia
16. J. Couvreur, P. Thulliez, and F. Daffos In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine Fetal Diagn Ther 8 1993 45 50
17. D. Dunn, M. Wallon, F. Peyron, E. Petersen, C. Peckham, and R. Gilbert Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling Lancet 353 1999 1829 1833
18. G. Gomez, A Espinal, and S.W. Lagakos Inference for a linear regression model with an interval-censored covariate Stat Med 22 2003 409 425
19. P.C. Austin, and J.S. Hoch Estimating linear regression models in the presence of a censored independent variable Stat Med 23 2004 411 429
20. S. Romand, M. Wallon, J. Franck, P. Thulliez, F. Peyron, and H. Dumon Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis Obstet Gynecol 97 2001 296 300
21. M.B. Mets, E. Holfels, and K.M. Boyer Eye manifestations of congenital toxoplasmosis Am J Ophthalmol 122 1996 309 324
22. M. Lebech, D.H. Joynson, and H.M. Seitz Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis Eur J Clin Microbiol Infect Dis 15 1996 799 805
23. L.S. Magder, and J.P. Hughes Logistic regression when the outcome is measured with uncertainty Am J Epidemiol 146 1997 195 203
24. R.E. Gilbert, and C.S. Peckham Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen 9 2002 135 141
25. R. Thiébaut, R.E. Gilbert, L. Gras, and G. Chêne Timing and type of prenatal treatment for congenital toxoplasmosis (protocol for a cochrane review) The Cochrane Library 2003 Update Software Oxford
26. N.G. Guerina, H.W. Hsu, H.C. Meissner The New England Regional Toxoplasma Working Group Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection N Engl J Med 330 1994 1858 1863
27. P.A. Jenum, B. Stray-Pedersen, and K.K. Melby Incidence of Toxoplasma gondii infection in 35, 940 pregnant women in Norway and pregnancy outcome for infected women J Clin Microbiol 36 1998 2900 2906
28. M. Lebech, O. Andersen, N.C. Christensen Danish Congenital Toxoplasmosis Study Group Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment Lancet 353 1999 1834 1837
29. R.E. Gilbert Toxoplasmosis M.L. Newel J. McIntyre Congenital and Perinatal Infections 1st ed. 2000 Cambridge University Press Cambridge 305 320
30. B. Evengard, K. Petersson, and M.L. Engman Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden Epidemiol Infect 127 2001 121 127
31. M. Paul, E. Petersen, and J. Szczapa Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznan region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies J Clin Microbiol 39 2001 1912 1916